Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-02-28 Option Award | 2022-03-02 6:11 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer | 10,400 | $0 | 32,115 (Direct) | View |
2022-02-02 Tax Withholding | 2022-02-04 4:57 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer | 742 | $45.03 | 21,715 (Direct) | View |
2022-01-31 Tax Withholding | 2022-02-01 6:46 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer | 210 | $45.94 | 22,457 (Direct) | View |
2022-01-07 Tax Withholding | 2022-01-11 4:42 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer | 90 | $50.63 | 22,667 (Direct) | View |
2022-01-05 Tax Withholding | 2022-01-07 4:39 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer | 1,511 | $50.69 | 22,757 (Direct) | View |
Ownership | 2021-10-07 7:03 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer | 0 | $0 | 105,362 (Direct) | View |